Sandoz Group AG (SWX:SDZ)
Switzerland · Delayed Price · Currency is CHF 65.76
-1.60 (-2.38%)
Jul 31, 2026, 5:30 PM CET
Sandoz Group AG Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,157 | 11,157 | 10,384 | 9,979 | 9,306 | 9,678 |
Revenue Growth | 5.38% | 7.44% | 4.06% | 7.23% | -3.84% | 0.21% |
Gross Profit Gross Profit Growth | 5,284 | 5,284 | 4,926 | 4,564 | 4,378 | 4,599 |
Operating Income Operating Income Growth | 1,425 | 1,425 | 307 | 375 | 1,239 | 1,394 |
Net Income Net Income Growth | 914 | 914 | 0 | 77 | 848 | 908 |
Earnings Per Share EPS Growth | 2.09 | 2.09 | - | 0.18 | 1.97 | - |
EPS Growth | 301.92% | - | - | -90.86% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biosimilars Biosimilars Growth | 3,474 | 3,292 | 2,853 | 2,215 | 1,928 | 1,945 |
Generics Generics Growth | 7,888 | 7,794 | 7,504 | 7,432 | 7,141 | 7,498 |
Revenue (Total) Revenue (Total) Growth | - | 11,157 | 10,384 | 9,979 | 9,306 | 9,678 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,739 | 1,739 | 1,191 | 1,109 | 74 | 40 |
Total Debt Total Debt Growth | 5,629 | 5,629 | 4,811 | 4,514 | 334 | 312 |
Net Cash (Debt) Net Cash Growth | -3,890 | -3,890 | -3,620 | -3,405 | -260 | -272 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -8.91 | -8.91 | -8.34 | -7.90 | -0.60 | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,594 | 1,594 | 656 | 362 | 1,223 | 1,354 |
Capital Expenditures CapEx Growth | -493 | -493 | -404 | -364 | -278 | -313 |
Free Cash Flow Free Cash Flow Growth | 1,101 | 1,101 | 252 | -2 | 945 | 1,041 |
Free Cash Flow Growth | 116.73% | 336.91% | - | - | -9.22% | 19.38% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.36% | 47.36% | 47.44% | 45.74% | 47.04% | 47.52% |
Operating Margin | 12.77% | 12.77% | 2.96% | 3.76% | 13.31% | 14.40% |
Pretax Margin | 10.82% | 10.82% | -0.11% | 1.30% | 11.84% | 13.57% |
Profit Margin | 8.19% | 8.19% | 0.01% | 0.80% | 9.13% | 9.40% |
FCF Margin | 9.87% | 9.87% | 2.43% | -0.02% | 10.15% | 10.76% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 1.009 | 0.662 | 0.534 |
Dividend Per Share Growth | 33.33% | 52.37% | 23.90% | - |
Dividend Yield | 1.22% | 1.00% | 1.21% | 0.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 39.68 | 34.95 | - | 178.73 | - | - |
Forward PE | 19.86 | 19.12 | 12.88 | 12.21 | - | - |
P/FCF Ratio | 32.59 | 28.71 | 70.33 | - | - | - |
PS Ratio | 3.22 | 2.83 | 1.71 | 1.39 | - | - |